CME and S&P offload OSTTRA in $3.1 billion deal
Deal is expected to close in H2 2025; current co-CEOs Guy Rowcliffe and John Stewart will remain at OSTTRA and continue to lead the company.
Deal is expected to close in H2 2025; current co-CEOs Guy Rowcliffe and John Stewart will remain at OSTTRA and continue to lead the company.
The options will be available on S&P 500 annual dividend index futures from 29 January.